A review of interventions and system changes to improve time to reperfusion for ST-segment elevation myocardial

Kelly A McDermott1, Christian D Helfrich, Anne E Sales

  • 1VA Puget Sound Health Care System, Seattle, WA, USA.

Insights

Quality improvement interventions significantly reduce reperfusion times for ST-segment elevation myocardial infarction (STEMI) patients. Process and system-level strategies show promise, but study design limitations impact current evidence.

Area of Science:

  • Cardiology
  • Healthcare Quality Improvement
  • Health Services Research

Background:

  • ST-segment elevation myocardial infarction (STEMI) requires rapid reperfusion therapy.
  • Timeliness of reperfusion is critical for patient outcomes.
  • Existing literature on interventions to expedite reperfusion needs synthesis.

Purpose of the Study:

  • To identify and describe interventions aimed at reducing reperfusion time in STEMI patients.
  • To categorize identified interventions into process-specific and system-level strategies.
  • To evaluate the effectiveness of these interventions based on reported outcomes.

Main Methods:

  • Systematic literature search across five major research databases (MEDLINE, CINAHL, EMBASE, Web of Science, Cochrane).
  • Inclusion of controlled and uncontrolled studies evaluating reperfusion time interventions.
  • Inductive categorization of interventions and data abstraction by multiple researchers to ensure accuracy.

Main Results:

  • 42 studies met inclusion criteria, identifying 11 intervention categories.
  • Interventions were classified as process-specific (e.g., ED thrombolysis) or system-level (e.g., quality improvement).
  • 76% of studies reported significant reductions in door-to-reperfusion times, with decreases ranging from 13-82%.

Conclusions:

  • Process and system-based quality improvement interventions are associated with improved door-to-reperfusion times in STEMI.
  • The literature is limited by weak study designs and insufficient implementation details.
  • Further research with robust methodologies is needed to optimize reperfusion strategies.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...